We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map
Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized
Higher tumor mutational burden is linked to improved survival across multiple cancer types.
Simultaneous multiplex immunohistochemistry can provide efficient testing of multiple targets when diagnosing and selecting treatment for cancer
A response to David Rimm’s letter that supports the role of PD-L1 testing in improving outcomes for cancer patients.
David L. Rimm
David Rimm challenges the sensitivity and reproducibility of a new assay for PD-L1 detection.
Techniques like droplet digital PCR technology can assist with early monitoring of cancer immunotherapy to ensure the right treatment for each patient
Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups
Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions
Send me the latest from The Pathologist.
Comprehensive genomic profiling assays provide extensive coverage of variants and immunotherapy biomarkers and increasingly enable physicians to provide cancer patients with more informed treatments.
by Thermo Fisher Scientific
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.